In our previous studies, we have found MTA1 overexpression as a novel factor that facilitates inflammation‐associated cancer initiation, epithelial‐to‐mesenchymal transition (EMT), and PCa progression associated with angiogenesis, invasiveness, and metastatic potential 10, 14. This evidence concerns the gene MTA1 and cancer.